Frank J. Williams's most recent trade in Evolent Health Inc - Ordinary Shares - Class A was a trade of 90,940 Class A Common Stock done at an average price of $10.3 . Disclosure was reported to the exchange on June 1, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.27 per share. | 01 Jun 2023 | 90,940 | 929,812 (1%) | 0% | 10.3 | 933,954 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 90,940 | 17,250 | - | - | Class A Common Option (right to buy) | |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Sale of securities on an exchange or to another person at price $ 29.74 per share. | 01 Jun 2023 | 49,026 | 819,812 (0%) | 0% | 29.7 | 1,458,033 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Sale of securities on an exchange or to another person at price $ 29.26 per share. | 01 Jun 2023 | 41,914 | 868,838 (1%) | 0% | 29.3 | 1,226,404 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 19,060 | 0 | - | - | Class A Common Option (right to buy) | |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.87 per share. | 01 Jun 2023 | 19,060 | 838,872 (0%) | 0% | 6.9 | 130,942 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Sale of securities on an exchange or to another person at price $ 29.75 per share. | 01 Jun 2023 | 9,969 | 910,752 (1%) | 0% | 29.8 | 296,578 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Sale of securities on an exchange or to another person at price $ 29.27 per share. | 01 Jun 2023 | 9,091 | 920,721 (1%) | 0% | 29.3 | 266,094 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 110,000 | 19,060 | - | - | Class A Common Option (right to buy) | |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Sale of securities on an exchange or to another person at price $ 36.29 per share. | 01 May 2023 | 110,000 | 819,812 (0%) | 0% | 36.3 | 3,991,900 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.87 per share. | 01 May 2023 | 110,000 | 929,812 (1%) | 0% | 6.9 | 755,700 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2023 | 110,000 | 129,060 | - | - | Class A Common Option (right to buy) | |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.87 per share. | 03 Apr 2023 | 110,000 | 929,812 (1%) | 0% | 6.9 | 755,700 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Sale of securities on an exchange or to another person at price $ 31.80 per share. | 03 Apr 2023 | 104,126 | 825,686 (0%) | 0% | 31.8 | 3,311,207 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Sale of securities on an exchange or to another person at price $ 32.37 per share. | 03 Apr 2023 | 5,874 | 819,812 (0%) | 0% | 32.4 | 190,141 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 400,000 | 1,026,479 (1%) | 0% | 0 | Class A Common Stock | |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 400,000 | 0 | - | - | Leveraged Restricted Stock Unit | |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Sale of securities on an exchange or to another person at price $ 34.62 per share. | 03 Mar 2023 | 116,311 | 819,812 (0%) | 0% | 34.6 | 4,026,687 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Sale of securities on an exchange or to another person at price $ 34.40 per share. | 03 Mar 2023 | 87,901 | 938,578 (1%) | 0% | 34.4 | 3,023,794 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Sale of securities on an exchange or to another person at price $ 35.01 per share. | 03 Mar 2023 | 2,455 | 936,123 (1%) | 0% | 35.0 | 85,950 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Sale of securities on an exchange or to another person at price $ 34.98 per share. | 01 Mar 2023 | 100,940 | 626,479 (0%) | 0% | 35.0 | 3,530,881 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.87 per share. | 01 Mar 2023 | 100,940 | 727,419 (0%) | 0% | 6.9 | 693,458 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 100,940 | 239,060 | - | - | Class A Common Option (right to buy) | |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Sale of securities on an exchange or to another person at price $ 34.97 per share. | 01 Mar 2023 | 9,060 | 626,479 (0%) | 0% | 35.0 | 316,828 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.84 per share. | 01 Mar 2023 | 9,060 | 635,539 (0%) | 0% | 3.8 | 34,790 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 9,060 | 0 | - | - | Class A Common Stock Option (right to buy) | |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 110,000 | 9,060 | - | - | Class A Common Stock Option (right to buy) | |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.84 per share. | 01 Feb 2023 | 110,000 | 736,479 (0%) | 0% | 3.8 | 422,400 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Sale of securities on an exchange or to another person at price $ 32.15 per share. | 01 Feb 2023 | 108,500 | 627,979 (0%) | 0% | 32.2 | 3,488,275 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Sale of securities on an exchange or to another person at price $ 32.66 per share. | 01 Feb 2023 | 1,500 | 626,479 (0%) | 0% | 32.7 | 48,990 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2023 | 110,000 | 119,060 | - | - | Class A Common Stock Option (right to buy) | |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.84 per share. | 03 Jan 2023 | 110,000 | 736,479 (0%) | 0% | 3.8 | 422,400 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Sale of securities on an exchange or to another person at price $ 27.12 per share. | 03 Jan 2023 | 106,708 | 629,771 (0%) | 0% | 27.1 | 2,893,921 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Sale of securities on an exchange or to another person at price $ 28.18 per share. | 03 Jan 2023 | 3,292 | 626,479 (0%) | 0% | 28.2 | 92,769 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.84 per share. | 01 Dec 2022 | 110,000 | 736,479 (0%) | 0% | 3.8 | 422,400 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 110,000 | 229,060 | - | - | Class A Common Stock Option (right to buy) | |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Sale of securities on an exchange or to another person at price $ 28.29 per share. | 01 Dec 2022 | 109,100 | 627,379 (0%) | 0% | 28.3 | 3,086,439 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Sale of securities on an exchange or to another person at price $ 29.09 per share. | 01 Dec 2022 | 900 | 626,479 (0%) | 0% | 29.1 | 26,181 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2022 | 110,000 | 339,060 | - | - | Class A Common Stock Option (right to buy) | |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.84 per share. | 01 Nov 2022 | 110,000 | 736,479 (0%) | 0% | 3.8 | 422,400 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Sale of securities on an exchange or to another person at price $ 29.36 per share. | 01 Nov 2022 | 57,438 | 640,929 (0%) | 0% | 29.4 | 1,686,380 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Sale of securities on an exchange or to another person at price $ 28.88 per share. | 01 Nov 2022 | 38,112 | 698,367 (0%) | 0% | 28.9 | 1,100,675 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Sale of securities on an exchange or to another person at price $ 30.26 per share. | 01 Nov 2022 | 13,773 | 627,156 (0%) | 0% | 30.3 | 416,771 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Sale of securities on an exchange or to another person at price $ 31.81 per share. | 01 Nov 2022 | 677 | 626,479 (0%) | 0% | 31.8 | 21,535 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Sale of securities on an exchange or to another person at price $ 35.75 per share. | 23 Aug 2022 | 150,000 | 752,434 (0%) | 0% | 35.8 | 5,362,500 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2022 | 150,000 | 449,060 | - | - | Class A Common Stock Option (right to buy) | |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.84 per share. | 23 Aug 2022 | 150,000 | 902,434 (1%) | 0% | 3.8 | 576,000 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2022 | 50,000 | 177,273 | - | - | Class A Common Stock Option (right to buy) | |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Sale of securities on an exchange or to another person at price $ 37.21 per share. | 23 Aug 2022 | 50,000 | 752,434 (0%) | 0% | 37.2 | 1,860,500 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.95 per share. | 23 Aug 2022 | 50,000 | 802,434 (0%) | 0% | 14.0 | 697,500 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 5,564 | 756,434 (0%) | 0% | 0 | Class A Common Stock | |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.76 per share. | 09 Jun 2022 | 3,860 | 752,434 (0%) | 0% | 28.8 | 111,014 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 382,489 | 0 | - | - | Leveraged Restricted Stock Unit | |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 382,489 | 940,298 (1%) | 0% | 0 | Class A Common Stock | |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.54 per share. | 02 Mar 2022 | 189,568 | 750,730 (0%) | 0% | 27.5 | 5,220,703 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.84 per share. | 17 Feb 2022 | 10,000 | 577,809 (0%) | 0% | 3.8 | 38,400 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2022 | 10,000 | 599,060 | - | - | Class A Common Stock Option (right to buy) | |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Sale of securities on an exchange or to another person at price $ 23.70 per share. | 17 Feb 2022 | 10,000 | 557,809 (0%) | 0% | 23.7 | 237,000 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Sale of securities on an exchange or to another person at price $ 23.70 per share. | 17 Feb 2022 | 10,000 | 567,809 (0%) | 0% | 23.7 | 237,000 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Sale of securities on an exchange or to another person at price $ 24.31 per share. | 18 Jan 2022 | 10,000 | 577,809 (0%) | 0% | 24.3 | 243,100 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jan 2022 | 10,000 | 609,060 | - | - | Class A Common Stock Option (right to buy) | |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Sale of securities on an exchange or to another person at price $ 24.30 per share. | 18 Jan 2022 | 10,000 | 567,809 (0%) | 0% | 24.3 | 243,000 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.84 per share. | 18 Jan 2022 | 10,000 | 587,809 (0%) | 0% | 3.8 | 38,400 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2021 | 66,064 | 66,064 (0%) | 0% | 0 | Class A Common Stock | |
| Evolent Health Inc (Class A) | Frank J. Williams | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2021 | 66,064 | 0 (0%) | 0% | 0 | Class A Common Stock | |
| Evolent Health Inc (Class A) | Frank J. Williams | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.84 per share. | 17 Dec 2021 | 10,000 | 597,809 (0%) | 0% | 3.8 | 38,400 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 26.64 per share. | 17 Dec 2021 | 10,000 | 587,809 (0%) | 0% | 26.6 | 266,400 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2021 | 10,000 | 619,060 | - | - | Class A Common Stock Option (right to buy) | |
| Evolent Health Inc (Class A) | Frank J. Williams | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 26.65 per share. | 17 Dec 2021 | 10,000 | 577,809 (0%) | 0% | 26.7 | 266,500 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 27.81 per share. | 17 Nov 2021 | 10,000 | 587,809 (0%) | 0% | 27.8 | 278,100 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2021 | 10,000 | 629,060 | - | - | Class A Common Stock Option (right to buy) | |
| Evolent Health Inc (Class A) | Frank J. Williams | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 27.81 per share. | 17 Nov 2021 | 10,000 | 597,809 (0%) | 0% | 27.8 | 278,100 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.84 per share. | 17 Nov 2021 | 10,000 | 607,809 (0%) | 0% | 3.8 | 38,400 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 30.35 per share. | 18 Oct 2021 | 10,000 | 607,809 (0%) | 0% | 30.4 | 303,500 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Oct 2021 | 10,000 | 639,060 | - | - | Class A Common Stock Option (right to buy) | |
| Evolent Health Inc (Class A) | Frank J. Williams | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 30.35 per share. | 18 Oct 2021 | 10,000 | 597,809 (0%) | 0% | 30.4 | 303,500 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.84 per share. | 18 Oct 2021 | 10,000 | 617,809 (0%) | 0% | 3.8 | 38,400 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.84 per share. | 17 Sep 2021 | 10,000 | 627,809 (0%) | 0% | 3.8 | 38,400 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Sep 2021 | 10,000 | 649,060 | - | - | Class A Common Stock Option (right to buy) | |
| Evolent Health Inc (Class A) | Frank J. Williams | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 26.27 per share. | 17 Sep 2021 | 10,000 | 607,809 (0%) | 0% | 26.3 | 262,700 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 26.27 per share. | 17 Sep 2021 | 10,000 | 617,809 (0%) | 0% | 26.3 | 262,700 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.84 per share. | 17 Aug 2021 | 10,000 | 637,809 (0%) | 0% | 3.8 | 38,400 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2021 | 10,000 | 659,060 | - | - | Class A Common Stock Option (right to buy) | |
| Evolent Health Inc (Class A) | Frank J. Williams | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 22.88 per share. | 17 Aug 2021 | 10,000 | 617,809 (0%) | 0% | 22.9 | 228,800 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 22.88 per share. | 17 Aug 2021 | 10,000 | 627,809 (0%) | 0% | 22.9 | 228,800 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 23.02 per share. | 02 Aug 2021 | 25,919 | 627,809 (0%) | 0% | 23.0 | 596,655 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2021 | 25,871 | 669,060 | - | - | Class A Common Stock Option (right to buy) | |
| Evolent Health Inc (Class A) | Frank J. Williams | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 23.02 per share. | 02 Aug 2021 | 25,871 | 653,728 (0%) | 0% | 23.0 | 595,550 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.84 per share. | 02 Aug 2021 | 25,871 | 679,599 (0%) | 0% | 3.8 | 99,345 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 23.02 per share. | 02 Aug 2021 | 6,165 | 653,728 (0%) | 0% | 23.0 | 141,918 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.84 per share. | 02 Aug 2021 | 6,144 | 666,037 (0%) | 0% | 3.8 | 23,593 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2021 | 6,144 | 694,931 | - | - | Class A Common Stock Option (right to buy) | |
| Evolent Health Inc (Class A) | Frank J. Williams | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 23.02 per share. | 02 Aug 2021 | 6,144 | 659,893 (0%) | 0% | 23.0 | 141,435 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.84 per share. | 30 Jul 2021 | 1,901 | 663,395 (0%) | 0% | 3.8 | 7,300 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 23.00 per share. | 30 Jul 2021 | 1,901 | 661,494 (0%) | 0% | 23 | 43,723 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2021 | 1,901 | 701,075 | - | - | Class A Common Stock Option (right to buy) | |
| Evolent Health Inc (Class A) | Frank J. Williams | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 23.00 per share. | 30 Jul 2021 | 1,601 | 659,893 (0%) | 0% | 23 | 36,823 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.84 per share. | 19 Jul 2021 | 10,000 | 681,494 (0%) | 0% | 3.8 | 38,400 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jul 2021 | 10,000 | 702,976 | - | - | Class A Common Stock Option (right to buy) | |
| Evolent Health Inc (Class A) | Frank J. Williams | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 21.60 per share. | 19 Jul 2021 | 10,000 | 661,494 (0%) | 0% | 21.6 | 216,000 | Class A Common Stock |
| Evolent Health Inc (Class A) | Frank J. Williams | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 21.60 per share. | 19 Jul 2021 | 10,000 | 671,494 (0%) | 0% | 21.6 | 216,000 | Class A Common Stock |